Echoism Explained: The Opposite of a Narcissist
Echoism is the opposite of narcissism. While a narcissistic person is very self-centered and always acts in their best interests, an echoist is someone who may often put others’ needs before their own.
Echoism is the opposite of narcissism. While a narcissistic person is very self-centered and always acts in their best interests, an echoist is someone who may often put others’ needs before their own.
According to a report, about 21 million people in the U.S. aged 12 years and older struggle with substance addiction every year. The National Institute on Drug Abuse (NIDA) shows expenditure due to lower production in the workplace, legal costs, and criminal justice is up to $600 billion.
A common side-effect of drinking that people often notice is bloating. The term “beer belly” is a common term used to describe the weight gain that often accompanies heavy or regular drinking.
Day trading is one of the many ways people can try to make money in the stock market. While day trading was nearly exclusively done by professionals such as large financial institutions, brokerages, or trading houses in the past, over the last several years, and thanks mainly to the Covid-19 pandemic, day trading has grown in popularity amongst the average “retail” investor.
Day Trading Addiction: A Guide to Compulsive Gamblers Read More »
May is Mental Health Awareness Month, a time for us to reflect on the importance of mental health in our lives and to educate ourselves and others on the challenges faced by those with mental health disorders.
A gambling addiction disorder, also known as compulsive gambling, is a mental health disorder characterized by a persistent and recurring urge to gamble despite the negative consequences that may result from placing bets.
Alcohol Awareness Month is an annual public health campaign held in April to increase awareness and education about alcohol-related issues. It was first established in 1987 by the National Council on Alcoholism and Drug Dependence (NCADD).
Abilify was first approved by the U.S. Food and Drug Administration (FDA) in 2002. Since that time it has become one of the most broadly-prescribed medications in the world.